For years, Ethereum has been the undisputed top crypto king of smart contracts and decentralized finance. However, recent price actions have caused even the mostFor years, Ethereum has been the undisputed top crypto king of smart contracts and decentralized finance. However, recent price actions have caused even the most

Ethereum (ETH) is Down 9% Over 30 Days, Investors Rotate Into This New Crypto V1 Protocol

4 min read

For years, Ethereum has been the undisputed top crypto king of smart contracts and decentralized finance. However, recent price actions have caused even the most loyal holders to reconsider their positions. As the market leader struggles to maintain its footing, a new wave of capital is flowing into emerging utility projects. 

One such project, Mutuum Finance (MUTM), has caught the attention of the “smart money” crowd. With its V1 protocol now live on the testnet, investors are rotating out of stagnating assets and into a protocol that offers a fresh take on decentralized credit.

Ethereum (ETH)

As of late January 2026, Ethereum is navigating a challenging landscape. The current price of ETH is hovering around $2,750, with a market capitalization that has retreated to approximately $332 billion. 

While Ethereum saw an early surge that momentarily pushed it toward the $5,000 mark last summer, that momentum has largely evaporated. Over the last 30 days alone, ETH has dropped by 9%, leaving many traders underwater. This decline is part of a broader trend where Ethereum has struggled to break through heavy resistance levels.

Looking ahead, some analysts are issuing a bearish price prediction for 2026 and 2027. If macro pressures continue and institutional demand for ETH ETFs cools down, there is a risk that the price could slide back into the $2,000 to $2,100 range. 

This potential stagnation has led to a “risk-off” sentiment among long-term holders. For those who used to rely on Ethereum for high-beta gains, the current environment feels stagnant, prompting a search for the next high-growth opportunity.

Mutuum Finance (MUTM)

While Ethereum faces a ceiling, Mutuum Finance (MUTM) is just beginning its journey. MUTM is currently in Phase 7 of its presale, with MUTM priced at an affordable $0.04. The project has already raised a staggering $20.1 million in funding, proving that there is deep liquidity and high demand for its vision. With more than 19,900 individual holders already on board, Mutuum Finance is building one of the most active communities in the 2026 crypto cycle.

Mutuum Finance is building a decentralized protocol. The goal is to allow users to lend and borrow assets without any middleman. Users can lock up their crypto as collateral to access instant cash, which is a vital tool for anyone who wants to hold their tokens long-term while still having spending power. By offering a dual-market system, the protocol caters to both passive lenders seeking high yields and active borrowers looking for flexible terms.

Why ETH Whales are Considering MUTM

In the last six months, Ethereum has lost a significant chunk of its market cap as investors grow tired of high gas fees and the slow pace of Layer-1 innovation. While Ethereum remains the base layer for many apps, it has become a “legacy asset” that struggles to deliver the explosive returns seen in previous years.

In contrast, Mutuum Finance has just reached a major technical milestone: the activation of its V1 protocol on the Sepolia testnet. This is a functional version of the app that users can actually test right now. Lenders receive yield-bearing receipts called mtTokens. These tokens grow in value automatically as interest is collected from borrowers. Borrowers receive debt-tokens to track their loans and interest in real-time.

Health Factor Monitoring helps users see how safe their loans are. If the value of collateral drops too low, an automated liquidator bot steps in to protect the system. By moving the protocol to a live test environment, Mutuum Finance has proven that its logic is operational.

Price Prediction and Security Standards

The price potential between these two assets is a primary driver for the current rotation. Analysts suggest that while Ethereum might struggle to see a 20% to 30% recovery back to $3,500 in 2026-2027, MUTM is positioned for much larger moves. With a confirmed launch price of $0.06, Phase 7 buyers are already looking at a built-in 50% discount. Experts who study the early cheap cryptocurrencies believe MUTM could 4x-10x by the end of 2026, as long as the roadmap unfolds as planned, representing a massive multiplier from the current presale price.

Security is another area where Mutuum Finance stands out. The project has already passed a full independent audit by Halborn Security, one of the top firms in the world. It also boasts a high 90/100 score from CertiK and a $50,000 bug bounty to keep the code safe. This combination of working tech, high security, and clear profit potential is exactly why the “smart money” is moving into MUTM today.

For more information about Mutuum Finance (MUTM) visit the links below:

Website: https://www.mutuum.com

Linktree: https://linktr.ee/mutuumfinance

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29